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Purpose: To identify the genes and noncoding RNAs (ncRNAs) involved in the neuroprotective actions of a dietary
antioxidant (saffron) and of photobiomodulation (PBM).
Methods: We used a previously published assay of photoreceptor damage, in which albino Sprague Dawley rats raised
in dim cyclic illumination (12 h 5 lux, 12 h darkness) were challenged by 24 h exposure to bright (1,000 lux) light.
Experimental groups were protected against light damage by pretreatment with dietary saffron (1 mg/kg/day for 21 days)
or PBM (9 J/cm2 at the eye, daily for 5 days). RNA from one eye of four animals in each of the six experimental groups
(control, light damage [LD], saffron, PBM, saffronLD, and PBMLD) was hybridized to Affymetrix rat genome ST arrays.
Quantitative real-time PCR analysis of 14 selected genes was used to validate the microarray results.
Results: LD caused the regulation of 175 entities (genes and ncRNAs) beyond criterion levels (p<0.05 in comparison
with controls, fold-change >2). PBM pretreatment reduced the expression of 126 of these 175 LD-regulated entities below
criterion; saffron pretreatment reduced the expression of 53 entities (50 in common with PBM). In addition, PBM
pretreatment regulated the expression of 67 entities not regulated by LD, while saffron pretreatment regulated 122 entities
not regulated by LD (48 in common with PBM). PBM and saffron, given without LD, regulated genes and ncRNAs beyond
criterion levels, but in lesser numbers than during their protective action. A high proportion of the entities regulated by
LD (>90%) were known genes. By contrast, ncRNAs were prominent among the entities regulated by PBM and saffron
in their neuroprotective roles (73% and 62%, respectively).
Conclusions: Given alone, saffron and (more prominently) PBM both regulated significant numbers of genes and
ncRNAs. Given before retinal exposure to damaging light, thus while exerting their neuroprotective action, they regulated
much larger numbers of entities, among which ncRNAs were prominent. Further, the downregulation of known genes
and of ncRNAs was prominent in the protective actions of both neuroprotectants. These comparisons provide an overview
of gene expression induced by two neuroprotectants and provide a basis for the more focused study of their mechanisms.
The photoreceptors (rods and cones) of mammalian retina
are the most specialized, metabolically active and fragile of
the nerve cells of the retina [1–3]. Photoreceptors are also the
most vulnerable of retinal cells to genetic stress, induced by
mutations  in  genes  whose  expression  is  specific  to
photoreceptors, and in ubiquitously expressed genes [4,5].
The breakdown of photoreceptor stability is a major element
of age-related retinal disease, and therefore of age-related
blindness [6].
The  stress-induced  death  of  photoreceptors  is
accompanied by damage to the survivors [7–9]. Both death
and damage appear to be caused by oxidative stress, i.e., by
the damaging effects of partially reduced forms of oxygen,
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often called reactive oxygen species. Absorption of light (the
normal function of photoreceptor outer segments) increases
oxidation  of  their  lipids,  creating  morphological  and
functional damage as light exposure is increased [10–12]. The
idea that light-induced damage is caused by oxidative stress
is  supported  by  evidence  that  levels  of  endogenous
antioxidants increase following light damage [13–15], and
that exogenous antioxidants are protective [15–21], for cones
[22,23] as well as rods.
We have explored the neuroprotective potential of the
ancient spice saffron, which shows a strong protective effect
against  light-induced  damage  of  photoreceptors  [24].  The
stigmata  of  Crocus  sativus  contain  powerful  antioxidants
(crocin, crocetin) in biologically high concentrations [25];
their  multiple  C=C  bonds  give  the  stigmata  their  color,
fragrance,  taste,  and  antioxidant  potential.  Their
concentration in saffron may be an evolutionarily special case,
as the plant is a sterile triploid bred by vegetative propagation
for its fragrance, taste, color, and medicinal properties. In a
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1801recent double blind clinical trial [26], saffron (2 μg/day over
12 weeks) induced a partial but consistent recovery of the
electroretinogram  elicited  from  the  macula,  and  of  visual
acuity. We have also pioneered the use of photobiomodulation
(PBM) as a retinal neuroprotectant. Red to infrared (600–
1,000 nm) light at low intensities promotes wound healing in
skin and oral mucosa [27], and protects photoreceptors from
toxin- [28], genetic- [29], and light-induced [30] damage.
Furthermore, it reduces laser-induced retinal scarring. PBM
delivered transcranially reduces cerebral pathology in animal
models  of  brain  damage  [31–33]  and  in  human  ischemic
stroke  [34].  PBM  acts  partly  by  repairing  mitochondrial
function  and  upregulating  oxidative  phosphorylation  [35].
Again, no harmful side effects have been reported at the doses
used in this in vivo work (daily doses of 5 J/cm2 or less). To
develop the understanding of these neuroprotective effects,
we have used microarray techniques to identify the genes
regulated by saffron and PBM in their protective actions.
METHODS
Experimental  organization:  The  protective  potential  of
dietary saffron, and of PBM, was tested using a light damage
assay. Animals were treated in accordance with the ARVO
Statement for the Use of Animals in Ophthalmic and Vision
Research, and with protocols approved by the ANU Animal
Ethics Committee. Young adult Sprague Dawley rats aged
P80–120 were reared in 5 lux cyclic light, and prepared in six
groups. Each group comprised two males and two females.
Control—These animals were raised in 5 lux cyclic light,
as above. They were routinely fed a vegetable (potato or rice)
matrix, developed as a biodegradable packaging material, and
we used the same matrix as vehicle for feeding them with
saffron.
Saffron-exposed  only—Animals  were  fed  saffron  at
1  mg/kg/day  for  3  weeks.  Saffron  (stigmata  of  Crocus
sativus, from the Abbruzzo region in Italy) was soaked in
water (at 2 mg of spice/ml H2O) and 12 h was allowed for the
major antioxidants, which are water-soluble [25], to dissolve
fully. The solute was then fed to the rats by injecting a small
volume into a piece of the vegetable matrix, which the animal
readily  ingested.  The  volume  for  each  daily  feed  was
calculated to provide the solutes from 1 mg of saffron/kg
bodyweight. Tissue was collected 24 h after the last feed.
Photobiomodulation-exposed  only—Animals  were
exposed to 670 nm red light from a WARP 75 source (60mW/
cm2, Quantum Devices Inc., Barneveld, WI). Animals were
handled gently over several days until they were adapted to
handling. Each was then gently restrained with a towel and
held under a Plexiglas platform with the head ~2.5 cm below
the platform. The WARP75 device was placed on top of the
platform and turned on for 3 min. This arrangement provided
a fluence of 9 J/cm2 at the eye. The animals did not hide from
or appear agitated by the red light. Animals were treated in
this  way  once  daily  for  5  days  at  9:00  AM.  Tissue  was
collected 24 h after the last treatment.
Light-damaged  only—The  animals  were  kept
individually in Plexiglas cages, with food kept on the floor of
the cages and water offered from transparent containers, to
ensure uniform exposure. After overnight dark adaptation,
animals were exposed to bright (1,000 lux) light for 24 h, from
a white fluorescent source. Exposure began and ended at 9:00
AM
TABLE 1. TAQMAN PROBES USED FOR QPCR
Name Gene symbol TaqMan assay ID
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) Agt Rn00593114_m1
Beta actin Actb (Control) Rn00667869_m1
carnitine O-octanoyltransferase Crot Rn00583174_m1
chemokine (C-C motif) ligand 2 Ccl2 Rn01456716_g1
endothelin 2 Edn2 Rn00561135_m1
fatty acid binding protein 5, epidermal Fabp5 Rn00821817_g1
fibroblast growth factor 2 Fgf2 Rn00570809_m1
glyceraldehyde-3-phosphate dehydrogenase Gapdh (Control) Rn99999916_s1
glial fibrillary acidic protein Gfap Rn00566603_m1
glutathione peroxidase 3 Gpx3 Rn00673916_g1
heme oxygenase (decycling) 1 Hmox1 Rn01536933_m1
optineurin Optn Rn00595346_m1
signal transducer and activator of transcription 3 Stat3 Rn00562562_m1
suppressor of cytokine signaling 3 Socs3 Rn00585674_s1
SWI/SNF related, matrix associated, actin dependent regulator of
chromatin, subfamily d, member 1
Smarcd1 Rn01533317_m1
Listing of all TaqMan probes used in this project including the reference genes Gapdh and Beta Actin.
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1802Saffron light damaged—Animals in this group were fed
saffron for 3 weeks, as above. At 9:00 AM on the last day of
feeding, they were exposed to damaging light for 24 h, as
above. Tissue was collected at the end of this 24 h period.
Photobiomodulation light damaged—Animals in this
group were exposed to PBM, as above, for 5 days. Beginning
at 9:00 AM on the last day of treatment, they were exposed to
damaging light for 24 h, as above. Tissue was collected at the
end of this 24 h period.
Tissue  collection:  At  the  points  in  the  protocol  specified
above, animals were euthanized with Lethabarb (60 mg/kg
intraperitoneally). The retina from one eye of each animal was
dissected free immediately, and placed in an individual tube
containing RNAlater (Ambion Biosystems, Austin, TX), and
stored  at  4  °C  overnight.  The  following  day,  tubes  were
transferred to –80 °C. The fellow eye was fixed by immersion
in  4%  (W/V)  paraformaldehyde  for  examination  of
morphology and immunohistochemistry.
Fellow eyes were marked on the superior aspect with
indelible  pen  for  future  orientation,  enucleated  and
immersion-fixed  in  4%  (W/V)  paraformaldehyde  for  3  h,
washed in 1× PBS (137 mM NaCl, 2.7 mM KCl, 10 mM
Na2HPO4,  2  mM  KH2PO4  at  pH  of  7.4)  thrice,  then
cryoprotected by immersion in 15% (W/V) sucrose overnight.
Eyes were sectioned at 12 μm on a cryostat in the superior-
inferior axis.
RNA extraction and analysis: RNA was extracted and purified
using previously published methods [36]. To determine the
Figure  1.  Photoreceptor  rescue  by
saffron  and  photobiomodulation.
Images  show  inner  and  outer  nuclear
layer  of  the  retina,  and  the  extent  of
damage  caused  by  light  damage  to  a
control  animal  (A),  to  a  animal
subjected to light damage (LD; B) and
to  an  animal  pre-treated  with
photobiomodulation and then subjected
to LD (C). The red label, applied with
the  TdT-mediated  dUTP  nick  end
labeling  (TUNEL)  technique,  marks
cells  whose  DNA  is  undergoing  the
fragmentation  characteristic  of
apoptotic death. TUNEL-positive cells
are confined to the ONL, i.e., they are
the  somas  of  photoreceptors.  The
number  of  TUNEL-positive  cells  is
reduced by PBM pretreatment. D: Mean
numbers of TUNEL-positive cells per
mm of outer nuclear layer, for control,
LD, SafLD, and PBMLD groups. The
reductions  in  cell  death  caused  by
pretreatment  with  saffron  and  PBM
were statistically significant.
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1803quantity and purity of the sample, RNA was analyzed on an
ND-1000  spectrophotometer  (Nanodrop  Technologies,
Wilmington,  DE)  and  a  2100-Bioanalyzer  (Agilent
Technologies, Santa Clara, CA). RNA samples were used
only if the A260/A280 ratio was above 1.8 and the RNA integrity
number was greater than 8.5.
Microarray analysis: To study the changes in gene expression
induced  in  the  six  experimental  groups,  we  used  18
Affymetrix (Santa Clara, CA) Rat Genome ST arrays. These
microarrays  contain  over  700,000  twenty-five-mer
oligonucleotide features representing 27,342 genes. Labeling,
hybridization, washing, and scanning of the microarray were
performed  at  the  Australian  Cancer  Research  Foundation
(ACRF) Biomolecular Resource Facility at the John Curtin
School of Medical Research, Australian National University,
following the manufacturers’ specifications. The arrays were
scanned on the Affymetrix GeneChip 3000 7G high resolution
scanner and analyzed using the GeneSpring GX v10 software
(Agilent  Technologies)  and  Partek  Genomic  Suite  6.4
Software  (Partek  Inc.,  St.  Louis,  MO).  The  hierarchical
clustering was performed using GeneSpring on the full entity
list (genes plus noncoding RNA [ncRNA]) for each of the six
groups.  Normalization  was  performed  using  the  Robust
Multichip  Average  (RMA)  algorithm  and  only  gene
expression levels with statistical significance (p<0.05) were
recorded as being “present” above background levels. Genes
with expression levels below this statistical threshold were
considered “absent.” For the box and whisker plot, we first
ran a multivariate ANOVA (ANOVA) analysis on the six
groups to identify genes whose expression was significantly
varied (p<0.05, fold-change >2). This yielded a list of 187
entities, from which the box and whisker plot was generated.
The Partek Genomic Suite was used to identify genes and
ncRNAs  whose  expression  differed  between  experimental
groups, typically between one experimental group and one
control group. Data in the form of a computerized version of
the .DAT file (CEL) files were imported and gene expression
values were derived using the RMA algorithm on the “core”
metaprobe list, which represents RefSeq genes and full-length
GenBank mRNAs. For each comparison between treatment
and control group, two-sample Student t tests were used to
calculate the probability P that the expression of a gene had
not  changed.  Genes  and  ncRNAs  whose  expression  was
significantly changed by treatment were selected using the
criteria that p<0.05 and the fold-change in expression >2. The
microarray  data  discussed  in  this  publication  have  been
uploaded  to  the  National  Center  for  Biotechnology
Information (NCBI’s) Gene Expression Omnibus [37] and are
accessible through gene expression omnibus (GEO) Series
accession number GSE22818.
Quantitative  polymerase  chain  reaction:  RNA  for
quantitative polymerase chain reaction (qPCR) was handled
in  the  same  way  as  RNA  extracted  for  the  GeneChip®
experiments.  Three  biologic  groups  were  used,  with  one
animal  in  each  treatment  group.  Superscript  III  and  the
accompanying standard protocol (Invitrogen, Carlsbad, CA)
were used to convert 1 µg of retinal RNA to cDNA (cDNA).
TaqMan®  (Applied  Biosystems,  Foster  City,  CA)  Gene
Expression Mastermix (Cat# 4369514) and probes (Table 1)
were used to assess the validity of gene expression changes
identified in the microarray experiment using a StepOne Plus
qPCR  machine  and  StepOne  software  v2.1  (Applied
Biosystems). Assays were performed in duplicate (to account
for individual sample variability) and biologic triplicate (to
account  for  biologic  variability),  with  fold  changes
determined using comparative cycle threshold (Ct; delta-delta
ct).  Both  glyceraldehyde  3-phosphate  dehydrogenase
(Gapdh) and β-actin (Actb) were used as reference genes in
all qPCR experiments.
Figure  1  shows  the  protection  of  light-stressed
photoreceptors in rat retina achieved in the current work,
confirming previous reports for saffron [24] and PBM [30].
Light stress caused the death of photoreceptors, shown as
TUNEL-labeling  of  cells  in  the  ONL  (Figure  1B).
Pretreatment with saffron or PBM reduced the number of
TUNEL-positive cells in the ONL (Figure 1C, for PBM), as
well as reducing the light-induced thinning of the ONL (data
not shown). When quantitative data were pooled (Figure 1D),
significant differences were apparent between the LD group
on the one hand, and the saffron-treated and PBM-treated
groups on the other (control versus LD, p<0.002 on two-tailed
t test; LD versus saffron LD, p<0.0025; LD versus PBMLD,
p<0.002).
TdT-mediated dUTP nick end labeling and quantification:
Cell death was assessed by the TdT-mediated dUTP nick end
labeling (TUNEL) technique to identify the fragmentation of
DNA characteristic of apoptotic cells, following a previously
published protocol [38] but using a fluorophore, Alexa 594,
to visualize the enzymatic reaction. TUNEL-labeled sections
were scanned from superior to inferior edge in 1 mm steps and
the number of TUNEL-positive profiles in each 1 mm of the
outer nuclear layer (ONL) was recorded. The frequency of
TUNEL-positive profiles per mm of ONL was averaged from
at least two sections per animal, and three or four animals were
analyzed for each condition. The Student t test was used to
compare the effects of different treatment conditions.
To  demonstrate  cell  survival,  the  DNA-specific  dye
bisbenzimide (Calbiochem, La Jolla, CA) was used. Sections
were incubated in the dye, diluted 1:10,000 in 1× PBS for 2
min at room temperature.
RESULTS
Global analyses of gene expression: Four approaches were
used  to  gain  an  overview  of  entity  (gene  and  ncRNA)
expression changes in the present data.
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1804Figure  2.  Hierarchical  clustering
diagram. This diagram shows the degree
of similarity/difference between the 18
samples used in this study. Each column
represents a sample; there were three
control  samples,  three  samples  from
retinas  (each  retina  from  a  different
animal) treated only with saffron, three
from retinas/animals treated only with
photobiomodulation (PBM), three from
retinas/animals treated only with light
damage  (LD),  three  from  retinas/
animals treated with PBM and LD, and
three from retinas/animals treated with
saffronLD. The columns are arranged so
that the most similar ones are next to
each other. The branching lines at the
top indicate in more detail the columns/
samples that are most similar/different.
A:  With  two  exceptions,  the  three
samples from each experimental group
resembled each other more than samples
in  other  experimental  groups.  The
exceptions  were  PBMLD1,  which
resembled  the  PBM  samples  more
closely  than  the  other  two  PBMLD
groups; saffronLD1, which resembled
the PBMLD samples more closely than
the other saffron LD groups. Of the three
treatments used (PBM, saffron, LD), LD
induced the most variable response by
all  assessments  used.  B:  When
expression values in the three samples
of each of the six experimental groups
were  averaged,  a  distinct  pattern  of
similarities emerged. The three saffron-
only samples were closer to control than
the PBM-only, suggesting that saffron
by itself regulates fewer genes/entities
than  PBM.  The  LD-treated  groups
clustered together, with the two treated
groups  (PBMLD  and  SaffronLD)
resembling each other more closely than
the  LD  group.  That  is,  treatment  by
PBM  and  Saffron  before  LD  had
broadly  similar  effects  on  the  LD-
induced regulation of genes/entities.
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1805Hierarchical  clustering  analysis—The  hierarchical
clustering of individual replicates (Figure 2A) indicates that
the patterns of gene expression in the three samples of each
group were highly reproducible. Of the 18 samples (3 samples
in each of 6 groups), 16 clustered most closely with samples
from the same group. One exception was PBMLD1, which
clustered with the PBM samples; the other was saffronLD1
(SafLD1), which clustered with two of the PBMLD samples.
Because  the  saffron  and  PBM  samples  clustered  closely
within their respective groups, the two exceptions suggest
some variability in the impact of LD on gene expression.
The  pattern  of  clustering  obtained  when  the  group
replicas were averaged is shown in Figure 2B. The three
samples exposed to LD cluster together, separate from the
three groups not exposed, indicating that LD has a strong
impact on retinal gene expression. In the three non-LD groups,
the saffron-treated sample clustered closer to control retina,
suggesting that PBM alone has a stronger effect on retinal
gene expression than saffron alone. Within the three LD-
exposed groups, the retinas also exposed to photoreceptor-
protective  treatment  (PBMLD,  SafLD1)  show  gene
expression  closer  to  each  other  than  to  the  LD  group,
suggesting that PBM and saffron modify the gene expression
induced by LD in broadly similar ways.
Distributions of gene expression in the six averaged
samples—the box and whisker plot—An overview of gene
expression in our six experimental groups is gained from the
“box and whisker” plot in Figure 3. There were 187 genes
included in these analyses; these were selected by a multi-
ANOVA analysis of the six experimental groups (p<0.05, fold
change [FC]>2).
For each sample, the plot shows the median expression
value of these genes as the horizontal line across the box. The
upper and lower ends of the box mark the first and third
quartile values, so that the box “contains” half of the sample
value;  the  extensions  show  1.5xIQR,  where  IQR  is  the
interquartile range for the sample. Expression values outside
the extensions are considered outlying values, and are shown
in red.
LD caused the median expression value to rise from the
control value, with the expression of many entities (genes or
ncRNAs)  lying  in  outlier  regions  (12  above,  16  below).
Saffron has relatively little effect on the distribution of gene
expression  levels,  but  PBM  narrows  the  distribution  and
creates outliers. These two protective treatments thus seem to
have distinctive effects. Finally, the effect of PBM and saffron
given before LD was to reduce the LD-induced increase of the
median  and  to  reduce  the  number  of  outliers  (to  none  in
PBMLD, one in saffron LD).
Venn  diagram  analysis:  entities  associated  with
neuroprotection  A  third  overview  of  entity  regulation
associated  with  the  neuroprotective  actions  of  PBM  and
saffron  is  given  by  a  Venn  diagram  analysis  (Figure  4);
numbers are shown separately for known genes and ncRNAs.
The diagram is applied to three sets of regulated entities—
those regulated by LD (compared to control); those regulated
Figure 3. “Box and whisker” plots of the
distributions of entity expression in the
six  experimental  groups  (replicates
averaged).  There  were  187  genes
included in these analyses; these were
selected by a multi-ANOVA analysis of
the six experimental groups (p<0.05, FC
> 2). For each sample, the plot shows the
median expression value of these genes
as the horizontal line across the box. The
upper and lower ends of the box mark
the first and third quartile values, so that
the box “contains” half of the sample
value;  the  extensions  show  1.5xIQR,
where IQR is the interquartile range for
the  sample.  The  red  lines  indicate
“outliers,”  genes  or  ncRNAs  whose
expression level was greater or less than
1.5xIQR from the median.
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1806by LD when preceded by PBM (compared to control): and
those regulated by LD when preceded by saffron feeding
(compared to control). LD regulated 175 entities. Of these, 50
(44 known genes, 6 ncRNAs) were not regulated beyond
criterion when LD was preceded by conditioning with PBM
(PBMLD) or with saffron (SafLD). That is, the expression of
these 50 entities (listed in Table 2) was suppressed by both
PBM and saffron conditioning. Their suppression may be
important in the protective actions of PBM and saffron.
When  saffron  was  given  to  the  animal  before  light
damage (SafLD), the expression of a large number of entities
(48 in common with PBM and 74 unique to saffron) were
regulated, and were not regulated by LD; i.e., their regulation
can  be  attributed  to  saffron  and  may  be  important  in  its
protective effect. Similarly, when the retina was conditioned
by PBM before exposure to LD, the expressions of 67 entities
(48 in common with saffron and 19 unique to PBM) was
regulated, which were not regulated by LD. Their regulation
can  be  attributed  to  PBM  and  may  be  important  in  the
protective effect of PBM. The entities regulated by saffron
and PBM given before LD, and not by LD, are listed in Table
3.
By  separating  known  genes  from  ncRNAs,  the  Venn
diagram  analysis  draws  attention  to  the  prominence  of
ncRNAs among the entities regulated by both saffron and
PBM when they are exerting their protective actions. For
example, LD regulated 175 entities, of which only 13 (7.5%)
were ncRNAs. Saffron preceding LD regulated 244 entities,
of which 83 (34%) were ncRNAs; while PBM preceding LD
regulated 116 entities, of which 51 (44%) were ncRNAs.
Among the 48 entities regulated by PBM and saffron, but not
by LD, and which are therefore potentially neuroprotective
entities, 39 (81%) were ncRNAs.
Expression changes: identified genes and noncoding
RNA Given the prominence of ncRNAs among the entities
regulated by saffron and PBM when conditioning LD, we
surveyed the relative numbers of genes and ncRNAs in the
seven comparisons shown in Figure 5A. As already noted, LD
regulated a large number of known genes, but few ncRNAs.
Conversely, ncRNAs outnumber known genes in the action
Figure  4.  Venn  Diagram  showing
similarity  and  differences  between
genes. The diagram is applied to three
sets of regulated entities: those regulated
by  light  damage  (LD;  compared  to
control); those regulated by LD when
preceded  by  photobiomodulation
(PBM; compared to control); and those
regulated  by  LD  when  preceded  by
saffron feeding (compared to control).
These sets were selected by two-sample
Student t test analysis (p<0.05) and fold-
change (FC>2).
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1809of PBM on the control retina (PBM versus control); in the
action of PBM when exerting its protective action against LD
(PBMLD versus LD); and in the protective action of saffron
(saffronLD versus LD). It seems likely that the regulation of
ncRNAs accounts for a significant part of the protective effect.
This  suggestion  is  supported  by  the  difference
comparison in Figure 5B. Measuring only changes in the
numbers  of  genes  and  ncRNAs  whose  expression  was
significantly regulated by saffron or PBM before LD, the
protective actions of saffron and PBM are both associated with
increases in the number of ncRNAs regulated, and decreases
in the numbers of identified genes whose expression was
regulated.
As a final step, we considered the directions of entity
expression changes in these several conditions (Figure 5C,
Figure 4D). The most striking outcome of this separation is
that the protective effects of PBM and saffron are associated
with a decrease in the number of known genes upregulated,
and an increase in the number of ncRNAs downregulated.
Validation by real-time PCR: Thirteen genes were chosen for
RT–PCR validation of the microarray outcomes; those chosen
were strongly regulated and/or retina-relevant. Five genes
(Crot,  Optn,  Edn2,  Smarcad1,  Gpx3)  were  significantly
regulated by saffron in the LD assay. Crot and smarcad1 are
involved in fatty acid metabolism, Edn2 in retinal signaling
in  response  to  injury,  and  Gpx3  in  antioxidative  activity.
Optn acts as an mgluR1 receptor on retinal bipolar cells.
Fabp5  is  also  saffron-regulated,  and  related  to  fatty  acid
metabolism. Fgf and GFAP are proteins upregulated by stress;
Stat3 and Socs3 are related to transduction pathways, ccl2 to
inflammatory  responses,  and  Agt  and  heme  oxygenase  1
(Hmox1) to cardiovascular control.
Figure 6 shows a comparison for each of the 13 genes
between  its  regulation  as  assessed  by  the  microarray
procedure and its regulation as assessed by RT–PCR. The
correlation between the two techniques appears particularly
close for ccl2, Socs3, Stat2, Cro, Edn2, Hmox1, Fabp5, and
smarcad. Common trends, with quantitative differences at
some sample points, are evident for Optn, GFAP, Agt, Fgf2,
and Gpx3. Overall, the correlation between the two techniques
seems strong.
Entities associated with the protective actions of saffron and
photobiolmodulation listed:
Light  damage–induced  regulation  inhibited  by
photobiolmodulation or saffron—The genes and ncRNAs
whose regulation by LD was inhibited by PBM or saffron are
listed  in  Table  2;  as  noted  above,  this  inhibition  affected
principally (88%) known genes (44 known genes, 6 ncRNAs).
All 50 entities were upregulated by LD; they are therefore
candidates  for  genes  and  regulatory  elements  whose
upregulation is damaging to photoreceptors.
Regulation by photobiolmodulation and saffron, but
not  LD—Table  3  lists  genes  and  ncRNAs  that  were  not
regulated by LD but were regulated by PBM and saffron when
conditioning (protecting) photoreceptors challenged by LD.
Figure 7 shows that the effects of PBM and saffron on their
regulation  were  highly  correlated.  The  entity  regulation
shown in Table 3 contrasts in two ways with the pattern of
regulation in Table 2: Most of the entities whose regulation
was changed by saffron and PBM conditioning were ncRNAs
Figure 5. Analysis of entities regulated
(known  genes  versus  ncRNAs)  and
direction of regulation. A: Numbers of
genes and ncRNAs regulated in seven
comparisons  among  the  experimental
groups.  SaffLD  is  the  group  given
saffron  before  light  damage  (LD).  B:
Effects  of  saffron  and
photobiomodulation  (PBM)  on  the
numbers  of  LD-induced  expression
changes of known genes and ncRNAs.
C:  Direction  of  regulation  of  known
genes by PBM and saffron when given
as pretreatments to LD. D: Direction of
regulation  of  ncRNAs  by  PBM  and
saffron when given as pretreatments to
LD.
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1810(81%), and all the ncRNAs and half the known genes were
downregulated.
Regulation by PBM or saffron, but not light damage
—Further candidates for genes and ncRNAs protective to
Figure  6.  Comparisons,  for  thirteen
selected genes, of expression changes in
the six experimental groups, assessed by
qPCR and microarray analysis.
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1811photoreceptors can be found in 74 entities (37 known genes,
37 ncRNAs) regulated by saffron (but not by PBM) when
conditioning/protecting photoreceptors (Table 4), and in the
19 entities (9 known genes, 10 ncRNAs) regulated by PBM
(but  not  by  saffron)  when  conditioning/protecting
photoreceptors (Table 5).
Regulation by LD, SaffronLD, and PBMLD—Genes
found  to  be  regulated  by  SaffronLD  and  LD  (Table  6),
PBMLD and LD (Table 7), and SaffronLD, PBMLD, and LD
(Table 8) are shown in the corresponding tables. These genes
are not discussed as the changes in expression levels are likely
due to LD and not saffron or PBM.
DISCUSSION
The present results provide an overview of gene and ncRNA
regulation associated with the neuroprotective actions of PBM
and saffron. The analyses used were chosen partly to provide
validation  of  the  method,  for  example  the  hierarchical
clustering  analysis  in  Figure  2  and  the  microarray-PCR
comparison in Figure 6. In addition, they allow a compare-
and-contrast discussion of the possible actions of saffron and
PBM.
The box-and-whisker presentation in Figure 3 suggests
that PBM and saffron acting on the retina in the absence of a
light challenge have distinct effects. Saffron has relatively
little effect on the expression of genes by the retina, but when
given as pretreatment to LD, saffron reduced the large changes
in gene expression induced by LD. PBM by itself had a much
more significant effect on retinal gene expression than saffron,
narrowing the distribution of entity expression changes and
generating many “outliers.” PBM given as pretreatment to LD
reduced the gene expression caused by LD toward control
levels.
The Venn diagram analysis allowed a logical separation
of lists of genes and ncRNAs whose regulation appears to
contribute to neuroprotection; it also draws attention to the
prominence of ncRNAs (rather than known genes) among the
entities regulated during the protective action of PBM and
saffron.
Figure 7. Evidence of similarity in the
actions  of  saffron  and
photobiomodulation. This graph shows
the correlation for 48 entities (9 known
genes  and  39  ncRNAs)  between  the
change  in  gene  expression  associated
with  photobiomodulation  (PBM)  and
saffron pre-treatments.
Molecular Vision 2010; 16:1801-1822 <http://www.molvis.org/molvis/v16/a196> © 2010 Molecular Vision
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1817Possible mechanisms of protection against light damage:
Our study builds upon previous work showing that there are
global changes in gene expression due to LD [39–42] and that
antioxidants can play a role in ameliorating this stress [15,
17,43,61].  A  direct  example  is  Hmox1,  which  has  been
previously found to be a marker for light-induced stress in the
retina  and  could  be  controlled  by  the  antioxidant
dimethylthiourea [43]. Our results also show a reduction in
the expression of Hmox1in both the LD saffron and PBMLD
treated samples. In contrast to these findings, a study by Sun
and  colleagues  reported  that  overexpression  of  Hmox1  is
protective to the retina [44]. This suggests that Hmox1 act as
a marker for light-induced stress rather than playing a role in
the etiology of the degeneration.
Tissue  antioxidant  proteins  have  been  reported  to  be
upregulated [13,14] or their activity increased [15] following
light  exposure;  among  others,  glutathiones  (Gpx1),
thioredoxin-1,  glutathione  peroxidase,  glutathione-S-
transferase, and glutathione reductase have been identified in
these findings. In the present study, we found Gpx3 gene
expression  showed  a  reduction  in  the  LD  animals.  Both
saffron and PBM mitigated the changes in gene expression
following LD, suggesting that both saffron and PBM have a
direct regulatory effect on tissue oxidative protection.
Another  possible  protective  mechanism  involved  in
saffron  and  PBM  treatment  is  through  the  reduction  of
inflammation due to the downregulation of chemokine (C-C
motif)  ligand  2  (ccl2).  CCL2  has  been  found  to  play  an
important  role  in  inflammation  by  inducing  leukocyte
recruitment and activation [45] [46]. It has been shown to be
elevated in many degenerative diseases of the central nervous
system, such as multiple sclerosis [47], Alzheimer disease
[48], Parkinson disease [49], and amyotrophic lateral sclerosis
[50]. In the eye, ccl2 has been shown to play a role in the
development  of  retinal  degeneration;  ccl2-deficient  mice
develop  age  related  macular  degeneration  (AMD)  like
symptoms [51]. Our results suggest that reducing ccl2 levels
to near control levels has a direct correlation with the amount
of cell death. Further investigation into the role of ccl-2 in LD
in the retina is required.
Different forms of neuroprotection: contrasts in entity
expression: LD was used in this study as an assay of the
protected/vulnerable status of photoreceptors. It is relevant to
recall,  however,  that  exposure  to  light  also  involves  a
neuroprotective  action  [52,53].  Prior  light  experience
regulates photoreceptor vulnerability to light; both ambient
light experienced over long periods and a briefer exposure to
very  bright  light  upregulate  mechanisms  that  protect  the
photoreceptors from a subsequent light challenge.
Recently,  we  [54]  drew  a  distinction  among
preconditioning  pretreatments  that  make  photoreceptors
resistant to LD. The distinction was between pretreatments
that damage photoreceptors (examples being light [above] or
hypoxia  [55])  but  nevertheless  protect  surviving
photoreceptors against subsequent stress, and pretreatments
that  are  protective  without  themselves  damaging
photoreceptors (examples being saffron [24] and PBM [28,
29]). The present results show that the regulation of entity
expression associated with light is very different from that
associated with a nondamaging pretreatment in at least two
ways.  First,  light  regulates  principally  known  genes,
upregulating them; by contrast, PBM and saffron regulate
large numbers of ncRNAs, mainly downregulating them.
How does saffron act?: The data provide some insight
into how saffron acts to protect photoreceptors against LD in
the present experiments. A simple, “direct action” hypothesis
for the action of an antioxidant is that it does not interact with
cells, but rather acts as a direct antioxidant, shortening the
lifespan of reactive oxygen species, and reducing the damage
they cause. This hypothesis would predict that saffron has
little effect on retinal gene expression, and this prediction is
not contradicted by the list of entities (data not shown) whose
expression was regulated significantly by saffron without LD.
The list is short (12 known genes, 5 ncRNAs), and only one
entity (an ncRNA) was regulated more than threefold. The
“direct  action”  hypothesis  appears  to  be  contradicted,
however, by the large number of genes and ncRNAs which
were significantly regulated by LD, and whose regulation was
reduced significantly by saffron preconditioning (Table 2);
and by the large number of genes and (especially) ncRNAs
whose expression was significantly regulated by saffron when
given as pretreatment to LD (Table 3 and Table 4). As already
noted (Figure 5), a large proportion of the entities regulated
in  these  two  ways  by  saffron  are  ncRNAs,  and  further
understanding of the protective action of saffron will require
understanding of the roles of these sequences.
With known genes, the present data allow mechanisms of
saffron-induced protection to be postulated for further study.
TABLE 7. GENES AND NCRNA REGULATED BY PHOTOBIOMODULATION LIGHT DAMAGE AND LIGHT DAMAGE.
Probeset ID Gene_assignment Gene symbol RefSeq p-value FC (LD/C) FC (PBMLD/C)
10855701 aquaporin 1 Aqp1 NM_012778 0.000296 −2.4813 −2.26193
10761128 heat shock protein 1 Hspb1 NM_031970 0.040669 5.7848 2.67409
10834613 RGD1307355 RGD1307355 NM_001107822 0.008949 2.02622 2.00283
        Genes regulated by both photobiomodulation (PBM) light damage (PBMLD) and LD when compared to control. The change
        in gene expressions indicate that these genes (3 genes in total) change in response to light damage and not the treatment paradigm.
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1819As  an  example,  one  of  the  genes  whose  expression  is
upregulated specifically by saffron as part of its protective
action against LD (Table 4) is endothelin 2. Expression of this
gene is associated with the upregulation of the protective/
trophic factor fibroblast growth factor-2 (FGF-2), which is
known  to  be  protective  against  photoreceptors  [56–58].
Upstream from endothelin 2, leukemia inhibitory factor is
known  to  upregulate  endothelin  2  as  part  of  the  Jak/Stat
pathway  [59];  leukemia  inhibitory  factor  expression  has
recently been shown to be protective to photoreceptors in the
rat  LD  model  [59].  Given  the  number  of  genes/entities
involved, much detailed work will be required to define the
mechanisms  of  the  saffron-induced  protection  of
photoreceptors.
How does photobiolmodulation act?: Previous analyses
of  the  neuroprotective  action  of  PBM  [29,35,60]  have
suggested that the energy of the radiation is absorbed by the
mitochondrial enzyme cytochrome oxidase, which serves the
key role of sequestering oxygen from the tissue for oxidative
phosphorylation  pathways,  and  the  production  of
adenosine-5'-triphosphate  (ATP).  The  result  includes
restoration  of  toxin-induced  loss  of  ATP  production  and
increased  cell  viability.  Several  studies  suggest  that  the
absorption  of  PBM  upregulates  intracellular  pathways
governing the redox state of the cell (reviewed [35]).
The present results confirm that PBM, given without LD,
changes retinal gene expression in a significant number of
entities, and that, given as a pretreatment to LD, PBM (like
saffron) changes the expression of a large numbers of entities,
reducing the LD-induced regulation of many (Table 2 and
Table 3) and regulating many not affected by LD (Table 5).
PBM,  like  saffron,  appears  to  regulate  many  intracellular
pathways when given as a pretreatment. As with saffron, a
large proportion of the entities regulated by PBM are ncRNAs,
and further understanding of the protective action of saffron
will require understanding to the roles of these sequences.
Neuroprotection: multiple pathways: The present results
add  to  the  knowledge  of  the  mechanisms  by  which
photoreceptors,  and  presumably  other  neurons,  can  be
protected  from  degeneration.  The  present  analysis  of  the
action of saffron suggests that its action is more than that of a
direct  antioxidant;  rather,  saffron  appears  to  interact  very
significantly with gene expression. Saffron is a complex of
molecules [25] that includes powerful antioxidants, as well as
a range of bioactive molecules. Which of these potentially
active molecules, or which combination of them, accounts for
the  neuroprotective  action  of  saffron  remains  to  be
determined.
PBM seems to act through at least two pathways, by
reducing inflammation and by reducing oxidative damage.
Future investigation of the ncRNAs regulated by PBM and
saffron  could  reveal  further  clues  to  their  mechanism  of
protection.
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